Cielo Provides Update on Corporate Matters
CALGARY, Alberta, April 14, 2025 ( GLOBE NEWSWIRE ) -- Cielo Waste Solutions Corp. ( TSXV: CMC; OTC PINK: CWSFF ) ( "Cielo" or the "Company" ) today provides an update on certain business and corporate matters. Cielo is pleased to announce that the corporate update webinar ( the "Webinar" ) ...
SKYWORKS SOLUTIONS, INC. ( NASDAQ: SWKS ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Skyworks Solutions, Inc. Investors of Upcoming Deadline - Skyworks Solutions ( NASDAQ:SWKS )
NEW YORK, April 14, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Skyworks Solutions, Inc. SWKS? Did you purchase your shares between July 30, 2024 and February 5, 2025, inclusive? Did you lose money in your investment in Skyworks Solutions, Inc.?
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry ...
Soleno Therapeutics Announces VYKAT ( TM ) XR Launch - Soleno Therapeutics ( NASDAQ:SLNO )
REDWOOD CITY, Calif., April 14, 2025 ( GLOBE NEWSWIRE ) -- Soleno Therapeutics, Inc. ( Soleno ) SLNO, a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the U.S. commercial availability of VYKAT⢠XR ( diazoxide choline ) extended-release ...
ROCKET LAB USA, INC. ( NASDAQ: RKLB ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Rocket Lab USA, Inc. Investors of Upcoming Deadline - Rocket Lab USA ( NASDAQ:RKLB )
NEW YORK, April 14, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Rocket Lab USA, Inc. RKLB? Did you purchase your shares between November 12, 2024 and February 25, 2025, inclusive? Did you lose money in your investment in Rocket Lab USA, Inc.?
Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort ...
Mike Lindell Media Corp. ( OTC Pink "FSBN" ) LindellTV White House Reporter Cara Castronuova Creates a Stir regarding a Question for Karoline Leavitt in the D.C. Press Room Conference Regarding The Health of President Donald J. Trump.
Legacy Media and a Few Writers Attempt to Create Controversy Over a Question and Positive Comments Made by Washington, D.C. Chief Correspondent Cara Castronuova on Friday in the White House Press Briefing Room as Reporters Laugh While Others are Left Stunned and Upset.
Aya Gold & Silver Announces Appointment of John Burzynski to the Board and Departure of Nikolaos Sofronis
MONTREAL, April 14, 2025 ( GLOBE NEWSWIRE ) -- Aya Gold & Silver Inc. ( TSX: AYA. OTCQX: AYASF ) ( "Aya" or the "Corporation" ) is pleased to announce the appointment of Mr. John Burzynski to its Board of Directors as an Independent Director, effective immediately.
VENTURE GLOBAL, INC. ( NYSE: VG ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Venture Global, Inc. Investors of Upcoming Deadline - Venture Global ( NYSE:VG )
NEW YORK, April 14, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Venture Global, Inc. VG? Did you purchase your shares in connection with the Company's January 24, 2025 IPO? Did you lose money in your investment in Venture Global, Inc.?
Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9 - Verve Therapeutics ( NASDAQ:VERV )
Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort